ProRelix Research

🎉 We’re Honoured & Grateful! 🎉

We are proud to share that ProRelix Research has been selected for the “MSME National Golden Business Excellence Award” for excellence in Quality CRO Business in Healthcare 🏆

This prestigious recognition has been approved by the Msme chamber of commerce.India&Dubai of Commerce and Industry of India, and we will be receiving the award at Vigyan Bhavan, New Delhi, on 16th February 2026.

This achievement reflects our team’s hard work, commitment to quality, and dedication to advancing healthcare and clinical research standards. A heartfelt thank you to our mentors, partners, clients, and team members for their continued trust and support.

We look forward to celebrating this milestone in Delhi and continuing our journey of excellence.

🚀 Registration Achieved!

We are proud to announce that ProRelix Services LLP is now a CDSCO-Registered Contract Research Organization ( )—further validating our commitment to regulatory excellence and operational integrity in clinical research.

As a globally active CRO, this registration strengthens our footprint in India’s regulated environment and enhances our ability to serve sponsors worldwide seeking quality, speed, and compliance.

✅ CDSCO Registration: Central Drugs Standard Control Organization (India)
🌍 Global Trial Ex*****on: US | EU | APAC
🔬 Therapeutic Expertise: Oncology | Immunology | Dermatology | Metabolic | Rare Diseases

Our integrated services include:

• Regulatory Strategy & Dossier Support
• Full-Service Clinical Operations (Phase I-IV)
• eClinical Technology (eCRF, ePRO, etc.)
• Site & Patient Engagement

Whether you're a biotech innovator, pharma sponsor, or medical device company, ProRelix Research stands as your regulatory-compliant and globally scalable partner.

📩 Connect with us to explore strategic collaborations or clinical trial support in India and beyond.

🔗 www.prorelixresearch.com